
Semaglutide Offers Functional and Vascular Gains in PAD and T2D, with Subodh Verma, MD, PhD
Updated data from the STRIDE trial demonstrate semaglutide’s beneficial effects on symptoms, quality of life, and disease progression in people with type 2 diabetes (T2D) and peripheral artery disease (PAD). These findings were presented by Subodh Verma, …